Index levels, the highest-scoring companies, institutional filings and official newsroom releases across the tracked universe — refreshed through the session.
| # | Company | Price | Today | 6M | Analysts | Risk | Score |
|---|---|---|---|---|---|---|---|
| 1 | ABBV AbbVie | $285.42 | Up 0.7% | Up 37% | Buy | Low | ▮▮ |
| 2 | LLY Eli Lilly | $1257.03 | Up 0.4% | Up 36% | Buy | Medium | ▮▮ |
| 3 | V Visa | $402.61 | Up 0.7% | Up 27% | Buy | Low | ▮▮ |
| 4 | COP ConocoPhillips | $146.51 | 3.4% |
Published broker targets. Opinions, revised often — not outcomes.
| Up 26% |
| Buy |
| Medium |
| ▮▮ |
| 5 | XOM Exxon Mobil | $178.98 | Up 2.5% | Up 22% | Hold | Low | ▮▮ |
| 6 | UNH UnitedHealth | $401.43 | Down 1.3% | Up 24% | Buy | Low | ▮▮ |
| 7 | CVX Chevron | $224.99 | Up 2.6% | Up 22% | Buy | Low | ▮▮ |
| 8 | AAPL Apple | $343.46 | Up 0.4% | Up 27% | Mixed | Low | 77 |
| 9 | MSFT Microsoft | $529.05 | Down 1.9% | Up 25% | Buy | Medium | ▮▮ |
| 10 | BRK-B Berkshire Hathaway | $532.02 | Up 1.2% | Up 12% | No coverage | Low | ▮▮ |
Ranked by Venuedepth ScoreVenuedepth ScoreA 1–100 reading of recent market behaviour: six-month trend, one-month trend and realised volatility. Not a rating or a recommendation. — out of 100, from six-month trend, one-month trend and realised volatility. It describes recent price behaviour across the 24 large caps tracked here, not the whole market, and it is not a rating or a recommendation.
Reported positions as of each filing date, not current holdings. What is a 13F?13F filingsA quarterly form that large US investment managers must file with the SEC, listing the US-listed shares they held at quarter end.